Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 4078346, 10 pages
https://doi.org/10.1155/2017/4078346
Review Article

Therapeutic Approaches and Role of ncRNAs in Cardiovascular Disorders and Insulin Resistance

Faculty of Information Technology, University of Moratuwa, Katubedda, Moratuwa, Sri Lanka

Correspondence should be addressed to Gamage Upeksha Ganegoda; kl.mou@gahskepu

Received 26 May 2017; Revised 25 July 2017; Accepted 2 August 2017; Published 19 September 2017

Academic Editor: Shashi Kant

Copyright © 2017 Kalupahana Irushi Pamodya Liyanage and Gamage Upeksha Ganegoda. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Cookson, L. Liang, G. Abecasis, M. Moffatt, and M. Lathrop, “Mapping complex disease traits with global gene expression,” Nature Reviews Genetics, vol. 10, no. 3, pp. 184–194, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Esteller, “Non-coding RNAs in human disease,” Nature Reviews Genetics, vol. 12, no. 12, pp. 861–874, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Storz, “An expanding universe of noncoding RNAs,” Science, vol. 296, no. 5571, pp. 1260–1263, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Kashi, L. Henderson, A. Bonetti, and P. Carninci, “Discovery and functional analysis of lncRNAs: methodologies to investigate an uncharacterized transcriptome,” Biochimica et Biophysica Acta, vol. 1859, no. 1, pp. 3–15, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. R. J. Taft, K. C. Pang, T. R. Mercer, M. Dinger, and J. S. Mattick, “Non-coding RNAs: regulators of disease,” Journal of Pathology, vol. 220, no. 2, pp. 126–139, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. F. Palazzo and E. S. Lee, “Non-coding RNA: what is functional and what is junk?” Hypothesis and Theory Article, vol. 6, no. 2, pp. 1–11, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. S. R. Eddy, “Non-coding RNA genes and the modern RNA world,” Nature Reviews Genetics, vol. 2, no. 12, pp. 919–929, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Gao, W. Xu, J. Wang, K. Wang, and P. Li, “The role and molecular mechanism of non-coding rnas in pathological cardiac remodeling,” International Journal of Molecular Sciences, vol. 18, no. 3, pp. 608–625, 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Iaconetti, C. Gareri, A. Polimeni, and C. Indolfi, “Non-coding RNAs: The 'dark matter' of cardiovascular pathophysiology,” International Journal of Molecular Sciences, vol. 14, no. 10, pp. 19987–20018, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Bronze-da-Rocha, “MicroRNAs expression profiles in cardiovascular diseases,” BioMed Research International, vol. 2014, Article ID 985408, 23 pages, 2014. View at Publisher · View at Google Scholar
  11. S. R. Filios and A. Shalev, “β-cell microRNAs: small but powerful,” Diabetes, vol. 64, no. 11, pp. 3631–3644, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Viereck and T. Thum, “Circulating noncoding RNAs as biomarkers of cardiovascular disease and injury,” Circulation Research, vol. 120, no. 2, pp. 381–399, 2017. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Hata, “Functions of microRNAs in cardiovascular biology and disease,” Annual Review of Physiology, vol. 75, pp. 69–93, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. V. Kameswaran and K. H. Kaestner, “The Missing lnc(RNA) between the pancreatic β-cell and diabetes,” Frontiers in Genetics, vol. 5, Article ID 200, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Fan, X. Weng, Y. Zhao, W. Chen, T. Gan, and D. Xu, “Circular RNAs in cardiovascular disease: an overview,” BioMed Research International, vol. 2017, Article ID 5135781, 9 pages, 2017. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Wilcox, “Insulin and insulin resistance,” The Clinical Biochemist Reviews, vol. 26, pp. 16–39, 2005. View at Google Scholar
  17. Y. Ding, X. Sun, and P.-F. Shan, “MicroRNAs and cardiovascular disease in diabetes mellitus,” BioMed Research International, vol. 2017, Article ID 4080364, 8 pages, 2017. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Chang, “Non-coding RNAs and berberine: a new mechanism of its anti-diabetic activities,” European Journal of Pharmacology, vol. 795, pp. 8–12, 2017. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Witkowski, A. Weithauser, T. Tabaraie et al., “Micro-RNA-126 reduces the blood thrombogenicity in diabetes mellitus via targeting of tissue factor,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 36, no. 6, pp. 1263–1271, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Hashimoto and T. Tanaka, “Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitus,” Journal of Human Genetics, vol. 62, no. 2, pp. 141–150, 2017. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. He, Y. Ding, B. Liang et al., “A systematic study of dysregulated MicroRNA in type 2 diabetes mellitus,” International Journal of Molecular Sciences, vol. 18, no. 3, article 456, 2017. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Ding, H. Huang, Y. Xu, H. Zhu, and C. Zhong, “MiR-222 in cardiovascular diseases: physiology and pathology,” BioMed Research International, vol. 2017, Article ID 4962426, 6 pages, 2017. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Y. Cao, Q. Li, Y. Miao et al., “The emerging role of MicroRNA-155 in cardiovascular diseases,” BioMed Research International, vol. 2016, Article ID 9869208, 5 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. E. M. Small and E. N. Olson, “Pervasive roles of microRNAs in cardiovascular biology,” Nature, vol. 469, no. 7330, pp. 336–342, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Shantikumar, A. Caporali, and C. Emanueli, “Role of microRNAs in diabetes and its cardiovascular complications,” Cardiovascular Research, vol. 93, no. 4, pp. 583–593, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Makki, P. Froguel, and I. Wolowczuk, “Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines,” ISRN Inflammation, vol. 2013, Article ID 139239, 12 pages, 2013. View at Publisher · View at Google Scholar
  27. R. A. McGregor and M. S. Choi, “microRNAs in the regulation of adipogenesis and obesity,” Current Molecular Medicine, vol. 11, no. 4, pp. 304–316, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Mangge, G. Almer, M. Truschnig-Wilders, A. Schmidt, R. Gasser, and D. Fuchs, “Inflammation, adiponectin, obesity and cardiovascular risk,” Current Medicinal Chemistry, vol. 17, no. 36, pp. 4511–4520, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Hulsmans, D. De Keyzer, and P. Holvoet, “MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis,” FASEB Journal, vol. 25, no. 8, pp. 2515–2527, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Omran, D. Elimam, K. A. Webster, L. A. Shehadeh, and F. Yin, “MicroRNAs: a new piece in the paediatric cardiovascular disease puzzle,” Cardiology in the Young, vol. 23, no. 5, pp. 642–655, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. M. R. Thomas and G. Y. H. Lip, “Novel risk markers and risk assessments for cardiovascular disease,” Circulation Research, vol. 120, no. 1, pp. 133–149, 2017. View at Publisher · View at Google Scholar · View at Scopus
  32. R. C. Ma, “Genetics of cardiovascular and renal complications in diabetes,” Journal of Diabetes Investigation, vol. 7, no. 2, pp. 139–154, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. T. C. Roberts and M. J. Wood, “Therapeutic targeting of non-coding RNAs,” Essays In Biochemistry, vol. 54, pp. 127–145, 2013. View at Publisher · View at Google Scholar
  34. G. Bussotti, C. Notredame, and A. J. Enright, “Detecting and comparing non-coding RNAs in the high-throughput era,” International Journal of Molecular Sciences, vol. 14, no. 8, pp. 15423–15458, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Washietl, I. L. Hofacker, and P. F. Stadler, “Fast and reliable prediction of noncoding RNAs,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 7, pp. 2454–2459, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Hüttenhofer and J. Vogel, “Experimental approaches to identify non-coding RNAs,” Nucleic Acids Research, vol. 34, no. 2, pp. 635–646, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Mortazavi, B. A. Williams, K. McCue, L. Schaeffer, and B. Wold, “Mapping and quantifying mammalian transcriptomes by RNA-Seq,” Nature Methods, vol. 5, no. 7, pp. 621–628, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. D. Veneziano, G. Nigita, and A. Ferro, “Computational approaches for the analysis of ncRNA through deep sequencing techniques,” Frontiers in Bioengineering and Biotechnology, vol. 3, article 77, 2015. View at Publisher · View at Google Scholar
  39. C. A. Dinarello, “Proinflammatory cytokines,” Chest, vol. 118, no. 2, pp. 503–508, 2000. View at Publisher · View at Google Scholar · View at Scopus